Skip to main content
Beginner 3 min read

What Does Hormone Receptor Status Mean?

Hormone receptor status tells whether cancer cells have receptors for estrogen or progesterone. It helps guide treatment.

NCI source:National Cancer Institute — Tests for Breast Cancer Biomarkers

Review status: AI-assisted, editorial review complete. Not reviewed by a clinician. How we check pages

The short answer

Hormone receptor status describes whether cancer cells have receptors for estrogen (ER) or progesterone (PR). It is common in breast cancer reports. Receptor-positive cancers may respond to hormone therapy, which is why the result helps guide treatment planning.

  • Hormone receptor status shows whether cancer cells have receptors for estrogen or progesterone.

  • It is written as ER (estrogen receptor) and PR (progesterone receptor), positive or negative.

  • Receptor-positive cancers may respond to hormone therapy.

  • The result helps guide treatment, not describe how far cancer has spread.

Choose how you want to read this

The whole article, with every detail and caution.

The short version

On many breast cancer pathology reports you will see hormone receptor status, usually written as ER and PR. These describe whether the cancer cells carry receptors for the hormones estrogen (ER) and progesterone (PR). The answer helps guide treatment. This page explains what the result means and what to ask your care team.

What the receptors do

Some cancer cells carry proteins that act like docking points for hormones. When estrogen or progesterone locks into one, it sends a signal that can help the cancer grow. A cancer with these receptors is called hormone receptor positive. A cancer without them is hormone receptor negative.

Your report lists ER and PR separately, each as positive or negative. MedlinePlus says a result is positive when at least 1% of cells in the sample have receptors. Your report may also give a percentage.

Why status guides treatment

This test matters because it opens or closes a specific treatment door:

  • Receptor positive. The cancer may respond to hormone therapy. That treatment lowers hormone levels, or blocks the receptors so the signal cannot get through. It adds a treatment option.
  • Receptor negative. NCI says these cancers probably will not respond to hormone-blocking treatment. Other options, such as chemotherapy, are available. Negative does not mean untreatable. It points the plan in a different direction.

One piece of a larger picture

Hormone receptor status describes the biology of the cancer cells. It does not say how far the cancer has spread. Care teams combine it with other features, such as HER2 status, grade, and stage. No single result decides everything.

What to ask

  • What is my ER and PR status?
  • Does it make hormone therapy an option?
  • How does it fit with my other results, such as HER2 status?

Your care team's reading of your full report is what applies to you.

Hormone receptor status can also change over time. If cancer comes back after treatment, your team may repeat the biopsy and retest the receptors.

Sources

A female doctor talks with an older man in an exam room, with a diagram of the colon shown on a computer screen and pamphlets on the counter nearby.

Common questions

What does hormone receptor positive mean?

It means the cancer cells have receptors for estrogen, progesterone, or both. These cancers can be fueled by those hormones, and they may respond to hormone therapy that lowers hormone levels or blocks the receptors. Your care team explains what this means for your treatment.

Is hormone receptor positive good or bad?

Receptor-positive status adds hormone therapy as a treatment option. But status is only one factor among several, and your care team weighs the whole picture.

What does ER and PR mean on my report?

ER stands for estrogen receptor and PR for progesterone receptor. Your report lists each as positive or negative, and sometimes as a percentage of cells that carry the receptor. Together they describe the hormone receptor status.

Does hormone receptor negative mean fewer options?

Receptor-negative cancers probably will not respond to hormone-blocking treatment, so other options, such as chemotherapy, are used. Being negative does not mean untreatable — it points the plan in a different direction. Your care team can explain the options.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

More words from this kind of report

Other guides in biomarker & genetic tests.

Your next step

Plain-language definitions for the words on your report.

Look up another report term
Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Prepared by Cancer Explained's AI-assisted editorial system

Written from National Cancer Institute material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-10-02 what this meansLast updated: 2026-08-11Next planned review: 2027-07-14

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.